BlackRock
CVRX icon

BlackRock’s CVRx CVRX Stock Holding History

BlackRock’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.4M Buy
1,245,459
+218,900
+21% +$1.41M ﹤0.01% 3854
2026
Q1 		$9.71M Sell
1,026,559
-34,528
-3% -$253K ﹤0.01% 3531
2025
Q4 		$7.53M Buy
1,061,087
+45,399
+4% +$414K ﹤0.01% 3631
2025
Q3 		$8.2M Sell
1,015,688
-10,316
-1% -$77.6K ﹤0.01% 3555
2025
Q2 		$6.03M Buy
1,026,004
+20,157
+2% +$139K ﹤0.01% 3683
2025
Q1 		$12.3M Buy
1,005,847
+89,782
+10% +$1.27M ﹤0.01% 3207
2024
Q4 		$11.6M Buy
916,065
+6,642
+0.7% +$81.9K ﹤0.01% 3354
2024
Q3 		$8.01M Buy
909,423
+33,670
+4% +$306K ﹤0.01% 3516
2024
Q2 		$10.5M Buy
875,753
+110,754
+14% +$1.28M ﹤0.01% 3364
2024
Q1 		$13.9M Sell
764,999
-38,435
-5% -$910K ﹤0.01% 3179
2023
Q4 		$25.3M Buy
803,434
+72,511
+10% +$1.36M ﹤0.01% 2878
2023
Q3 		$11.1M Buy
730,923
+26,581
+4% +$437K ﹤0.01% 3272
2023
Q2 		$10.9M Buy
704,342
+643,425
+1,056% +$7.85M ﹤0.01% 3377
2023
Q1 		$568K Buy
60,917
+23,641
+63% +$313K ﹤0.01% 4501
2022
Q4 		$684K Buy
37,276
+973
+3% +$12K ﹤0.01% 4523
2022
Q3 		$340K Sell
36,303
-58,126
-62% -$460K ﹤0.01% 4830
2022
Q2 		$568K Sell
94,429
-305,216
-76% -$1.76M ﹤0.01% 4734
2022
Q1 		$2.39M Buy
399,645
+4,233
+1% +$34.2K ﹤0.01% 4313
2021
Q4 		$4.84M Buy
395,412
+48,254
+14% +$700K ﹤0.01% 4006
2021
Q3 		$5.74M Buy
+347,158
New +$6.66M ﹤0.01% 3904

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock's CVRX Position: Q2 2026 in Review

BlackRock increased its CVRx (CVRX) stake by 21% in Q2 2026, buying an estimated $1.41M and bringing the position to 1,245,459 shares worth $6.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3854.

BlackRock first reported a position in CVRX in Q3 2021 and has held it in 20 quarters since. The position peaked at $25.3M in Q4 2023. 87 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

  • BlackRock held 1,245,459 shares of CVRx worth $6.4M as of Q2 2026.
  • BlackRock bought 218,900 CVRx shares in Q2 2026, an estimated $1.41M.
  • CVRx made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3854 holding.
  • BlackRock first reported a position in CVRx in Q3 2021 and has held it in 20 quarters since.
  • BlackRock's CVRx position peaked at $25.3M in Q4 2023.
  • 87 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.